Oxford Medical Simulation Raises $12.6M in Series A Funding

Oxford Medical Simulation

Oxford Medical Simulation, a Boston, MA-based company which specialized in virtual reality healthcare training, raised $12.6M in Series A funding.

The round was led by Frog Capital with follow-on capital from ACF Investors, existing shareholders and strategic partners.

The company intends to use the funds to expand operations, scale its offering across learner groups, expand the use of AI across its solutions, and further support clients in building their own content.

Founded in 2017 and led by Michael Wallace, CEO, OMS is dedicated to training nurses, doctors, and allied healthcare professionals via a learning platform that bridges theory and practice with immersive simulation scenarios. Offering in-depth insights into clinical performance, OMS allows healthcare systems and academic institutions to scale their education, training and assessment.

The company works with institutions to support the healthcare workforce at every stage – from their first lesson in nursing school through clinical training and continuing professional development. It currently delivers over 35,000 simulations per month.

Commenting on the news, Michael Wallace said: “This investment allows us to rapidly scale the team whilst staying true to our vision and values. Frog’s experience in helping scale impact-focused software companies, combined with the significant expertise of our healthcare advisory board, will facilitate this expansion at a critical time for OMS and the healthcare workforce. But these innovations are not just about technology; they’re about people – training healthcare professionals more effectively to improve patient care, and this funding isn’t just an investment in Oxford Medical Simulation; it’s an investment in every healthcare professional we train. Our journey so far has been incredible, and it’s only just beginning.

FinSMEs

16/01/2024